CHARLOTTESVILLE, VA – January 11, 2024 – Luminoah Inc., a medical technology company dedicated to improving the standard of care for patients requiring enteral nutrition, has been awarded a $463,000 grant from Virginia Catalyst. This funding propels Luminoah’s innovative enteral feeding system one step closer to commercialization, poised to grant millions of users the freedom to feed themselves anytime, anywhere, while empowering healthcare providers to support their patients remotely.
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that it has awarded $2.2 million in grants to four life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded through Grant Round 15 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.
“This grant will accelerate our efforts,” says Neal Piper, Founder and CEO. “Born from a personal need right here in Virginia, we’re proud to collaborate with two of Virginia’s leading universities: The University of Virginia and Virginia Commonwealth University. This grant marks a significant milestone for Luminoah, propelling us towards bringing our transformative technology to the millions who need it most. It’s a testament to the power of collaboration, innovation, and unwavering dedication to improving healthcare for all.”
Mike Grisham, CEO, Virginia Catalyst said, “We are excited to fund this cohort of companies and their collaborating university partners on these important life science innovations. Together, they will have a significant impact on economic development in the Commonwealth of Virginia while improving human health.”
Through this 15th round of funding, Virginia Catalyst has awarded 61 grants totaling $29.7 million, resulting in over $47 million in matching funds and an additional $821 million in follow-on funding to date.
Other Grant Round 15 project awardees include Adovate, LLC (Charlottesville, VA), Nanochon, Inc. (Washington, DC), and S1P Therapeutics, Inc. (Blacksburg, VA)
About Luminoah
Luminoah is a medical technology company dedicated to improving the standard of care for patients requiring enteral nutrition. The company’s portable, intuitive, and connected nutrition system creates a new reality for patients and providers, enabling the freedom to feed anytime, anywhere with robust data tracking and remote patient monitoring. To learn more, visit Luminoah.com.
About Virginia Catalyst
Virginia Biosciences Health Research Corporation (VBHRC), doing business as Virginia Catalyst, has a vision of advancing life sciences throughout Virginia as a means of addressing large unmet medical needs to improve human health and to create high-paying jobs throughout the Commonwealth. Funded by the Virginia General Assembly’s General fund, the University of Virginia, Virginia Commonwealth University, Virginia Tech, Eastern Virginia Medical School, George Mason University, and Old Dominion University. Virginia Catalyst has funding opportunities to support collaborative projects in the Commonwealth. For more information, visit www.virginiacatalyst.org.
###